BARCELONA, Spain — A new randomized trial of embolization of the middle meningeal artery (EMMA) following surgery for chronic subdural hematoma showed striking results, with a major drop in hematoma recurrence. In the EMMA-CAN trial, patients who underwent the embolization procedure were six times less likely to experience symptomatic hematoma recurrence during the 90-day follow-up …
Benefit of Embolization for Subdural Hematoma Confirmed

Leave a Comment Leave a Comment
